Scinai Immunotherapeutics Ltd. Quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest in USD from Q4 2021 to Q4 2022
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.
-
Summary
-
Scinai Immunotherapeutics Ltd. quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest history and growth rate from Q4 2021 to Q4 2022.
- Scinai Immunotherapeutics Ltd. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest for the quarter ending December 31, 2022 was -$1.76M, a 279% decline year-over-year.
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Quarterly (USD)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, YoY Quarterly Growth (%)